276 related articles for article (PubMed ID: 7916188)
1. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
Pergolizzi RG; Erster SH
Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
[TBL] [Abstract][Full Text] [Related]
2. Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q.
Budarf M; Emanuel BS; Mohandas T; Goeddel DV; Lowe DG
Cytogenet Cell Genet; 1989; 52(1-2):19-22. PubMed ID: 2558855
[TBL] [Abstract][Full Text] [Related]
3. The molecular genetics of meningiomas.
Collins VP; Nordenskjöld M; Dumanski JP
Brain Pathol; 1990 Sep; 1(1):19-24. PubMed ID: 1688296
[TBL] [Abstract][Full Text] [Related]
4. Deletions on chromosome 22 in sporadic meningioma.
Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
[TBL] [Abstract][Full Text] [Related]
5. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
Dumanski JP; Rouleau GA; Nordenskjöld M; Collins VP
Cancer Res; 1990 Sep; 50(18):5863-7. PubMed ID: 2393856
[TBL] [Abstract][Full Text] [Related]
7. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22.
Rose TM; Lagrou MJ; Fransson I; Werelius B; Delattre O; Thomas G; de Jong PJ; Todaro GJ; Dumanski JP
Genomics; 1993 Jul; 17(1):136-40. PubMed ID: 8406444
[TBL] [Abstract][Full Text] [Related]
8. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
10. The gene for human leukemia inhibitory factor (LIF) maps to 22q12.
Sutherland GR; Baker E; Hyland VJ; Callen DF; Stahl J; Gough NM
Leukemia; 1989 Jan; 3(1):9-13. PubMed ID: 2491897
[TBL] [Abstract][Full Text] [Related]
11. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
12. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Wellenreuther R; Kraus JA; Lenartz D; Menon AG; Schramm J; Louis DN; Ramesh V; Gusella JF; Wiestler OD; von Deimling A
Am J Pathol; 1995 Apr; 146(4):827-32. PubMed ID: 7717450
[TBL] [Abstract][Full Text] [Related]
17. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
18. Characterization of several DNA polymorphic markers in the LIF gene region.
Moreau-Aubry A; Andre MT; Devilder MC; Resche F; Delattre O; Thomas G; Moisan JP
Hum Genet; 1994 Oct; 94(4):450-1. PubMed ID: 7927349
[TBL] [Abstract][Full Text] [Related]
19. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.
Dumanski JP; Carlbom E; Collins VP; Nordenskjöld M
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9275-9. PubMed ID: 2892198
[TBL] [Abstract][Full Text] [Related]
20. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22.
Giovannini M; Djabali M; McElligott D; Selleri L; Evans GA
Cytogenet Cell Genet; 1993; 64(3-4):240-4. PubMed ID: 8404048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
